Latest Kaiser Health News Stories
Obria, a Christian medical chain, was awarded federal family planning funds for its California clinics for the first time this year. Clinics receiving Title X funds are expected to treat and prevent sexually transmitted diseases. Obria’s prohibition against condoms means its prevention efforts rest on abstinence, even as STD rates surge.
The legal fight over the Trump administration’s new rule barring health clinics that receive federal family planning grants from referring women for abortion services played out before a divided federal appeals court Monday. Here are key takeaways.
Simple alterations — like better signs, seating, parking or door design — can make it easier for older patients to navigate health care facilities. Here are several changes doctors’ offices, clinics and hospitals could make.
An amino acid infusion called NAD is not approved by the FDA to treat addiction. Yet patients with addiction can be desperate enough to try it, at prices as high as $15,000.
The Trump administration’s policy shift on Title X family planning funds is likely to make birth control harder to get and more expensive for low-income women. It will also shift funds from organizations like Planned Parenthood to the Obria Group, which does not give women hormonal contraceptives or condoms in its clinics.
An encounter with a cat led to rabies shots and provided yet another illustration of how confusing, contrary and expensive the American health care system is.
California’s stem cell agency, created by a $3 billion bond measure 15 years ago, is almost out of money. Its supporters plan to ask voters for even more funding next year, even though no agency-funded treatments have been approved for widespread use.
A small health center in Goshen, Ind., near the border with Michigan, puts “listening to patients’ stories” first. “The rest is housekeeping.”
Tennessee company’s Medicare billings for urine tests were examined by Kaiser Health News in 2017.
Regenexx, which runs a string of clinics, says stem cell injections can save employers a lot of money, but critics say there’s no proof.
Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Paige Winfield Cunningham of The Washington Post join KHN’s Julie Rovner to discuss the Trump administration’s efforts to curtail federally funded research using fetal tissue, the backlash from former Vice President Joe Biden’s support for the anti-abortion Hyde Amendment and how health policy intersects with both trade and immigration policy.
While Missouri’s final abortion clinic may stop providing the procedure this week, women in the state had already been seeking care in neighboring states as regulations increasingly limited abortion access.
Under the rule that took effect this year, Medicare will lower payments for clinic visits performed at hospital-owned facilities to a rate that is equivalent to what it pays an independent doctor. Federal officials expect the move will save the government $380 million this year.
Critics are concerned about the explosion in controversial stem cell procedures offered by clinics — and, increasingly, respected hospitals.
The new regulation would drop previous rules for the Title X program requiring that women with unintended pregnancies be told about all options, including abortion. It would also mandate that organizations separate facilities providing federally funded services from those providing abortions.
The number of health clinic orders and shots administered rose sharply in January compared with last year, Washington county officials say.
Standards have been proposed to address what are often viewed as disparities in treatment, but the Trump administration has declined to enforce them.
Many areas in the U.S. depend on foreign doctors, but bitter political arguments over immigration have sown concerns about limited opportunities for these physicians.
The measure, which will appear on the November ballot, seeks to cap industry profits. The SEIU-UHW union has raised almost $17 million, but opponents from the industry have invested more than four times that.
Federal family planning funds, known as Title X, will soon fund for-profit women’s clinics that bar condoms, hormonal birth control and IUDs and offer only “natural family planning.”